In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.

The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...

Novo Nordisk A/S upgraded to Hold as FDA tightens compounded GLP-1s;Hims & Hers Health, Inc. stays Buy. Click for this NVO ...

The FDA has moved to exclude semaglutide, tirzepatide and liraglutide -- which are in several popular weight loss drugs -- ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

The FDA proposed Thursday not adding three active ingredients in weight-loss drugs to its so-called bulks list.

The FDA proposes excluding Novo Nordisk and Eli Lilly's weight-loss drugs from active ingredients used by outsourcing ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

Agency proposal would exclude semaglutide, tirzepatide, and liraglutide from 503B bulks li ...

Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) climbed Thursday after the U.S. Food and Drug Administration said it may tighten limits on pharmacies that make compounded versions of popular GLP-1 ...

FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise ...